108P Copy loss enrichment at metastatic disease progression in hormone receptor-positive (HR+)/HER2-negative metastatic breast cancer patients treated with endocrine therapy and CDK4/6 inhibition
Davis, A.A., Luo, J., Zheng, T., Dai, C., Suresh, R., Ademuyiwa, F.O., Rigden, C., Clifton, K., Weilbaecher, K., Frith, A.E., Tandra, P., Summa, T., Thomas, S., Peterson, L., Wang, X., Du, P., Jia, S., King, B.L., Krishnamurthy, J., Ma, C.X.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
Syndecan_1 and heparanase enhance VEGF association with endothelia
Yang, Y., Frith, A.E., Theus, A., MacLeod, V., Sanderson, R.D.
Published in Matrix biology (01.11.2006)
Published in Matrix biology (01.11.2006)
Get full text
Journal Article